13F-HR filed by Decheng Capital Management III (Cayman), LLC
Decheng Capital Management III (Cayman), LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-10, with 24 holding rows worth $247,862,218.
- Accession
- 0001104659-23-058221
- Filer
- CIK 1747821
- Filed
- 2023-05-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 24 entries on the cover page, a total value of $247,862,218 stated on the cover page (in dollars after the unit check, H1), rows summing to $247,862,218 with VALUE read as dollars as filed, 13F file number 028-22474. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Alabama Power 5.20% Div Qualif | 010392595 | PFD | 6,708,288 | $51,787,983 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 1,824,583 | $31,382,828 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 359,554 | $20,059,518 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 80,859 | $18,803,760 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 1,463,872 | $16,951,638 | dollars as filed | |
| CUE HEALTH INC | 229790100 | COM | 8,980,909 | $16,345,254 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 150,000 | $16,098,000 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 869,790 | $15,864,970 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 27,429 | $10,219,497 | dollars as filed | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 78,900 | $8,611,146 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 714,285 | $8,457,134 | dollars as filed | |
| BEYONDSPRING INC | G10830100 | SHS | 4,958,143 | $5,553,120 | dollars as filed | |
| SEATTLE GENETICS INC | 812578102 | COM | 23,014 | $4,659,645 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 526,329 | $3,810,622 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 904,268 | $3,716,541 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 580,000 | $3,340,800 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 4,447,308 | $3,246,535 | dollars as filed | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 293,333 | $2,722,130 | dollars as filed | |
| ATRICURE INC | 04963C209 | COM | 46,259 | $1,917,436 | dollars as filed | |
| SCYNEXIS INC | 811292200 | COM NEW | 555,555 | $1,666,665 | dollars as filed | |
| SEMA4 HOLDINGS CORP | 81663L101 | COM | 3,418,929 | $1,247,909 | dollars as filed | |
| Pyxis Oncology, Inc (formerly Apexigen) | 03759B102 | COM | 1,894,551 | $922,646 | dollars as filed | |
| OWLET INC | 69120X107 | COM | 898,400 | $291,441 | dollars as filed | |
| Ohr Pharmaceutical Inc | 64132K102 | COM | 1,000,000 | $185,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-058221 | this filing | 2023-05-10 | acceptance time not in the bulk data set |